vialauditThe Roundup
CJC-1295 WITH DAC·US LEGAL STATUS·LAST CHECKED 12 OCT 2026

Is CJC-1295 with DAC legal?

Not as a drug. CJC-1295 with DAC has no FDA approval, so selling it for human use breaks federal drug law, and a 'research use only' label does not protect a seller whose site signals human use. It is not a controlled substance, and possessing it is not a federal crime. Pharmacies cannot compound it.

RESEARCH-LABELLED SALE
Unapproved drug
PHARMACY COMPOUNDING
No · PCAC voted against
PRESCRIPTION
No approved product
WADA 2026
Prohibited (S2.2.4)

DESCRIBES THE LAW · NOT LEGAL ADVICE · NO DOSING INFORMATION

Federal, compounding and sport status

CHECKED 12 OCT 2026

Federal status

FDA approval
no approval
DEA scheduling
not scheduled
503A compounding
FDA interim category: Nominated but withdrawn (off Category 2, not eligible)
503A Bulks List: voted no
Not eligible. The PCAC voted 13-0 against every DAC form on 4 Dec 2024. FDA now lists CJC-1295 under 'nominated but withdrawn' (no longer Category 2), which does not permit compounding.
PCAC review history
  • Dec 4, 2024 · voted against · 13 no, 0 yes on each DAC form · SOURCE ↗
FDA Warning Letters
none on record for this compound
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: PCAC vote and Category 2 posture mean any human-use marketing is an FDCA §505/§301 violation.
Personal possession: Not federally criminalized (federal). State scheduling in Florida creates criminal exposure.

Sport-body status

WADA 2026
prohibited · class S2.2.4 · in and out of competition
CJC-1295 is named under S2.2.4 (GHRH analogues).
USADA
NCAA

What we couldn’t verify

State rules

NONE FOUND

We found no state statute, board rule or enforcement action that names CJC-1295 with DAC. The federal position above applies in all 50 states and DC.

What changed at the last check

3 CHANGES
DateFieldWasNowWhy
12 Oct 2026FDA Category 2 (safety risk)on listnot on listFDA's Category 2 page lists it under 'nominated but withdrawn', not in Category 2. source ↗
12 Oct 2026WADA 2026prohibited (S2.2)prohibited (S2.2.4)CJC-1295 is named under S2.2.4 (GHRH analogues). source ↗
12 Oct 2026FL state noteFlorida § 893.03(3) (HB 1041, eff. 2013 10 01) explicitly schedules CJC 1295 as Schedule III. Possession/distribution ofremovedRemoved. Florida Statutes §893.03 (2025) names no peptide, GHRH analogue or GH secretagogue in Schedule III; the earlier entry was wrong. source ↗

Questions

3 ANSWERS
Is CJC-1295 with DAC legal in the US?

Not as a drug. CJC-1295 with DAC has no FDA approval, so selling it for human use breaks federal drug law, and a 'research use only' label does not protect a seller whose site signals human use. It is not a controlled substance, and possessing it is not a federal crime. Pharmacies cannot compound it.

Can a pharmacy compound CJC-1295 with DAC?

Not eligible. The PCAC voted 13-0 against every DAC form on 4 Dec 2024. FDA now lists CJC-1295 under 'nominated but withdrawn' (no longer Category 2), which does not permit compounding.

Is CJC-1295 with DAC banned in sport?

Yes. It is prohibited at all times under WADA 2026 class S2.2.4. CJC-1295 is named under S2.2.4 (GHRH analogues).

Sources

6 DOCUMENTS
  1. FDA approval record
  2. DEA controlled-substance schedules
  3. FDA 503A compounding position
  4. PCAC review, 4 Dec 2024
  5. WADA 2026 Prohibited List
  6. Source for: FL state note
THE ROUNDUP · MONTHLY

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 SUBSCRIBERS·0 SPONSORED ITEMS·11 ISSUES SINCE LAUNCH